Effectiveness of Lanzhou Lamb Rotavirus Vaccine and RotaTeq Against Hospitalized Rotavirus Infections Among Children During 2020-2023 in Guangdong Province, China: A Test-Negative Case-Control Study
Both RV5 and LLR provided protection against RVGE, including the emerging G8P[8] genotype. Three doses of RV5 offered strong protection, while two doses of LLR also appeared to be an effective strategy against rotavirus infection.
Authors
- Ruili Xie (ORCID: https://orcid.org/0000-0003-4573-9805)
- Yingtao Zhang (ORCID: https://orcid.org/0000-0002-8587-9645)
- Zhuhang Huang (ORCID: https://orcid.org/0000-0001-8766-3576)
- Yawen Jiang (ORCID: https://orcid.org/0000-0002-0498-0662)
- Min Kang
- Biao Zeng (ORCID: https://orcid.org/0000-0002-7891-4086)
- Caixia Li (ORCID: https://orcid.org/0000-0003-2190-655X)
- Liling Lin (ORCID: https://orcid.org/0000-0001-6915-0582)
- Yi Yao (ORCID: https://orcid.org/0000-0003-4374-2955)
- Fen Yang (ORCID: https://orcid.org/0000-0002-2636-4975)
- Jun Liu (ORCID: https://orcid.org/0009-0007-0470-221X)
- Hailong Zhang (ORCID: https://orcid.org/0000-0003-4337-2480)
Institutions
- Shenzhen University (CN)
- Guangzhou Center for Disease Control and Prevention (CN)
- Shenzhen Center for Disease Control and Prevention (CN)
- Guangdong Institute of Biological Products and Drugs (CN)
- Shenzhen University Health Science Center (CN)
- Guangdong Provincial Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1007/s40121-024-01040-y
- Citations
- 4
- Primary Topic
- Viral gastroenteritis research and epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.56
Funders
- Guangdong Medical Research Foundation